News

FDA recall medical device recall product recall

Thousands of heart surgery kits recalled due to FDA quality concerns

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]

TAVR with Edwards Lifesciences valve for severe AR linked to ‘encouraging’ data

All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

Investigational heart drug for nonobstructive HCM one step closer to FDA approval

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?

passport visa foreign international travel

Radiologists say visa-processing delays could pose potential patient care crisis

ACR and other medical societies recently wrote to the secretaries of State and Homeland Security to voice their concern about ongoing staffing issues.

Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings.

CMS projection: 90% of Americans will still have health insurance in 2034—when healthcare spending reaches $9T

Legislative changes, demographic shifts and growing demand will combine to drive national health spending to almost $9 trillion by 2034.

In 3-game healthcare series, underdog large-language models sweep specialized AI powerhouses

Pitting three multipurpose LLMs against two healthcare-specific AI tools, researchers have discovered the consumer-level AI can beat its purpose-built counterparts in healthcare scenarios—and soundly, at that.

Kaiser Permanente to pay community hospital over $82M to resolve out-of-network reimbursement dispute

The lawsuit dates back to 2019 but has been stuck in the court process for years. In the end, the health plan will pay Pomona Valley Hospital for emergency care delivered to patients at an out-of-network rate—though the facility didn’t get all of what it was seeking.

Researcher undergoes over 100 MRI scans to understand how sleep affects the brain

Armed with an advanced 7T MRI and one very committed graduate student, researchers are gaining new insight into how sleep patterns affect brain health.

Memorial Sloan Kettering sues GE HealthCare alleging 'willful' patent infringement

The lawsuit claims that GE HealthCare's “MotionFree” imaging technology actually was developed by someone at the noted New York-based cancer center.

Michael Coords, MD, FSCCT, Medical Director of Cardiovascular Imaging, RadNet, a leader with the SCCT Health Policy and Practice Committee Regulatory Task Force, and incoming co-chair of the Health Policy and Practice Committee, says SCCT offers a unique blend of clinical education, business strategy, and networking to stay on top of CCTA's rapid proliferation.

Radiologists: Take the deep dive into advanced cardiovascular CT at SCCT

SCCT offers a unique blend of clinical education, business strategy, and networking to stay on top of CCTA's rapid proliferation.

Ronen Rubinshtein, MD, FACC, FESC, director, heart institute, Edith Wolfson Medical Center, in Holon, Israel, president elect for the Society of Cardiovascular Computed Tomography (SCCT), and chairman of the SCCT 2026 annual scientific meeting, explains plaque imaging, AI and structural heart disease are the spotlight at the meeting.

Plaque imaging, AI and structural heart disease in the spotlight at SCCT 2026 meeting

Coronary plaque imaging is an area many experts believe is driving a shift toward earlier detection and prevention of heart disease.

Around the web

Cardiovascular Business

Thousands of heart surgery kits recalled due to FDA quality concerns

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

Cardiovascular Business

TAVR with Edwards Lifesciences valve for severe AR linked to ‘encouraging’ data

All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

Cardiovascular Business

Investigational heart drug for nonobstructive HCM one step closer to FDA approval

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?